fda bpc-157 not approved for human use warning unapproved peptide safety risks fda warning bpc An FDA advisory committee is

The rapid attainment of peak plasma levels with parenteral administration makes this formulation particularly suitable for acute correction of deficiency states or for protocols requiring high systemic exposure

BPC-157/TB-500 Blend 20 mg For invitro laboratory research use only

The frustration is real, and the science is finally catching up to it

Repeated freeze-thaw cycles should be strictly avoided, as these degrade peptide integrity and introduce unwanted variability into experimental results

For optimal results within a research setting, please adhere to standard laboratory protocols for reconstitution using bacteriostatic water or research-grade solvent appropriate for each compound